Modified cDNA for high expression levels of factor VIII and its derivatives

Details for Australian Patent Application No. 2004283833 (hide)

Owner Negrier, C.

Inventors Ducasse, Cecille; Hauser, Hans-Peter; Plantier, Jean-Luc; Negrier, Claude

Agent Griffith Hack

Pub. Number AU-A-2004283833

PCT Pub. Number WO2005/040213

Priority 03023637.6 16.10.03 EP

Filing date 13 October 2004

Wipo publication date 6 May 2005

International Classifications

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040213 Priority application(s): WO2005/040213

6 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283842-CCR3 receptor antagonists

2004283832-Solid-state montelukast